Celularity Inc. Files 8-K for Material Agreement

Ticker: CELUW · Form: 8-K · Filed: Mar 21, 2025 · CIK: 1752828

Sentiment: neutral

Topics: material-definitive-agreement, equity-securities, corporate-action

Related Tickers: CELU

TL;DR

Celularity Inc. filed an 8-K on March 17, 2025, for a material definitive agreement concerning unregistered equity sales.

AI Summary

On March 17, 2025, Celularity Inc. entered into a material definitive agreement related to unregistered sales of equity securities. The company, formerly known as GX Acquisition Corp. until September 12, 2018, is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.

Why It Matters

This filing indicates a significant event for Celularity Inc., potentially involving new equity financing or strategic partnerships that could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Filings related to material definitive agreements and unregistered equity sales can signal significant corporate actions that may carry inherent risks for investors.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement Celularity Inc. entered into?

The filing indicates a material definitive agreement related to unregistered sales of equity securities, but the specific details of the agreement are not provided in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on March 17, 2025.

What was Celularity Inc.'s former company name?

Celularity Inc.'s former company name was GX Acquisition Corp.

On what date did Celularity Inc. change its name from GX Acquisition Corp.?

Celularity Inc. changed its name from GX Acquisition Corp. on September 12, 2018.

In which state is Celularity Inc. incorporated?

Celularity Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding Celularity Inc (CELUW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing